Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of antacid on oral calcitonin pharmacokinetics
2006-004177-95Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of TBRIA in osteoporosis and osteoarthritis (OA) (3 arms), sponsored by Novartis. Started Sep 2006; status: completed.
02
Drugs
TBRIA
03
Conditions
osteoporosisosteoarthritis (OA)
Beyond the preview
Go deeper on 2006-004177-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004177-95.